EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats Article

Zhang, Wenbin, Welihinda, Ajith, Mechanic, Jordan et al. (2011). EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats . Pharmacological Research, 63(4), 284-293. 10.1016/j.phrs.2011.01.001

International Collaboration

cited authors

  • Zhang, Wenbin; Welihinda, Ajith; Mechanic, Jordan; Ding, Haifeng; Zhu, Liangcheng; Lu, Yuan; Deng, Zhongping; Sheng, Zelin; Lv, Binhua; Chen, Yuanwei; Roberge, Jacques Y; Seed, Brian; Wang, Yong-Xiang

sustainable development goals

authors

publication date

  • April 1, 2011

published in

keywords

  • COTRANSPORTER SGLT2
  • DAPAGLIFLOZIN
  • DIABETIC-RATS
  • Diabetes
  • EGT1442
  • ETABONATE
  • EXPRESSION
  • KIDNEY
  • Life Sciences & Biomedicine
  • PHLORHIZIN
  • Pharmacology & Pharmacy
  • RENAL GLUCOSURIA
  • SERGLIFLOZIN
  • SGLT2 inhibitor
  • Science & Technology
  • Stroke-prone rats
  • TRANSPORTER
  • Urinary glucose excretion
  • db/db mice

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD

start page

  • 284

end page

  • 293

volume

  • 63

issue

  • 4